{"transactions":[{"id":12465,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-03-03T23:10:14.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":23812,"price":232.08,"value":5526288.96,"ownership":{"direct":true},"balance_after":83171,"source":{"system":"sec-edgar","filing":"0001761675-26-000004","document":"form4-03032026_060311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000176167526000004/form4-03032026_060311.xml","form_type":"4"}},{"id":13231,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Option (Right to Buy)","published_at":"2026-02-20T23:35:24.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":26812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 8,938 on February 18, 2027, 8,937 on February 18, 2028, and 8,937 on February 18, 2029."}],"balance_after":26812,"derivative":{"exercise_price":230.04,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":26812},"source":{"system":"sec-edgar","filing":"0001761675-26-000002","document":"form4-02202026_060213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000176167526000002/form4-02202026_060213.xml","form_type":"4"}},{"id":13230,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:24.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":8988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 13, 2025. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":106983,"source":{"system":"sec-edgar","filing":"0001761675-26-000002","document":"form4-02202026_060213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000176167526000002/form4-02202026_060213.xml","form_type":"4"}},{"id":13229,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:24.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":9432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 15, 2024. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":97995,"source":{"system":"sec-edgar","filing":"0001761675-26-000002","document":"form4-02202026_060213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000176167526000002/form4-02202026_060213.xml","form_type":"4"}},{"id":13228,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:24.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":9266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":88563,"source":{"system":"sec-edgar","filing":"0001761675-26-000002","document":"form4-02202026_060213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000176167526000002/form4-02202026_060213.xml","form_type":"4"}},{"id":13227,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2026-02-20T23:35:24.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":26063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2026."}],"balance_after":79297,"source":{"system":"sec-edgar","filing":"0001761675-26-000002","document":"form4-02202026_060213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000176167526000002/form4-02202026_060213.xml","form_type":"4"}},{"id":25233,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Option (Right to Buy)","published_at":"2025-04-02T21:00:09.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":25700,"price":79.02,"value":2030814.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":79.02,"expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":25700},"source":{"system":"sec-edgar","filing":"0001415889-25-009687","document":"form4-04022025_050401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925009687/form4-04022025_050401.xml","form_type":"4"}},{"id":25232,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-04-02T21:00:09.000Z","date":"2025-03-31","kind":"sale","planned":false,"acquired":false,"shares":33132,"price":210.54,"value":6975611.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.54 to $210.63, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53234,"source":{"system":"sec-edgar","filing":"0001415889-25-009687","document":"form4-04022025_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925009687/form4-04022025_050401.xml","form_type":"4"}},{"id":25231,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-04-02T21:00:09.000Z","date":"2025-03-31","kind":"sale","planned":false,"acquired":false,"shares":25700,"price":209.49,"value":5383893.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.43 to $209.60, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86366,"source":{"system":"sec-edgar","filing":"0001415889-25-009687","document":"form4-04022025_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925009687/form4-04022025_050401.xml","form_type":"4"}},{"id":25230,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-04-02T21:00:09.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":25700,"price":79.02,"value":2030814.0,"ownership":{"direct":true},"balance_after":112066,"source":{"system":"sec-edgar","filing":"0001415889-25-009687","document":"form4-04022025_050401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925009687/form4-04022025_050401.xml","form_type":"4"}},{"id":26184,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-03-04T22:00:15.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":20226,"price":205.02,"value":4146734.52,"ownership":{"direct":true},"balance_after":86366,"source":{"system":"sec-edgar","filing":"0001415889-25-006582","document":"form4-03042025_050312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925006582/form4-03042025_050312.xml","form_type":"4"}},{"id":28006,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Option (Right to Buy)","published_at":"2025-02-18T22:00:20.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":33854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,285 on February 13, 2026, 11,285 on February 13, 2027, and 11,284 on February 13, 2028."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,285 on February 13, 2026, 11,285 on February 13, 2027, and 11,284 on February 13, 2028."}],"balance_after":33854,"derivative":{"exercise_price":192.86,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":33854},"source":{"system":"sec-edgar","filing":"0001415889-25-004462","document":"form4-02182025_050216.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004462/form4-02182025_050216.xml","form_type":"4"}},{"id":28005,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-18T22:00:20.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":9432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 15, 2024. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":106592,"source":{"system":"sec-edgar","filing":"0001415889-25-004462","document":"form4-02182025_050216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004462/form4-02182025_050216.xml","form_type":"4"}},{"id":28004,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-18T22:00:20.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":9268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":97160,"source":{"system":"sec-edgar","filing":"0001415889-25-004462","document":"form4-02182025_050216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004462/form4-02182025_050216.xml","form_type":"4"}},{"id":28003,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-18T22:00:20.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":7840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":87892,"source":{"system":"sec-edgar","filing":"0001415889-25-004462","document":"form4-02182025_050216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004462/form4-02182025_050216.xml","form_type":"4"}},{"id":28002,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2025-02-18T22:00:20.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":19111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2025."}],"balance_after":80052,"source":{"system":"sec-edgar","filing":"0001415889-25-004462","document":"form4-02182025_050216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588925004462/form4-02182025_050216.xml","form_type":"4"}},{"id":42705,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Option (Right to Buy)","published_at":"2024-03-20T21:00:11.000Z","date":"2024-03-18","kind":"exercise","planned":false,"acquired":false,"shares":26110,"price":61.36,"value":1602109.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":61.36,"exercise_date":"2018-02-16","expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":26110},"source":{"system":"sec-edgar","filing":"0001415889-24-008760","document":"form4-03202024_050301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924008760/form4-03202024_050301.xml","form_type":"4"}},{"id":42704,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-20T21:00:11.000Z","date":"2024-03-18","kind":"sale","planned":false,"acquired":false,"shares":27740,"price":178.69,"value":4956860.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.60 to $178.87, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60941,"source":{"system":"sec-edgar","filing":"0001415889-24-008760","document":"form4-03202024_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924008760/form4-03202024_050301.xml","form_type":"4"}},{"id":42703,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-20T21:00:11.000Z","date":"2024-03-18","kind":"sale","planned":false,"acquired":false,"shares":5099,"price":179.03,"value":912873.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.00 to $179.11, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":88681,"source":{"system":"sec-edgar","filing":"0001415889-24-008760","document":"form4-03202024_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924008760/form4-03202024_050301.xml","form_type":"4"}},{"id":42702,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-20T21:00:11.000Z","date":"2024-03-18","kind":"sale","planned":false,"acquired":false,"shares":26110,"price":178.85,"value":4669773.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.85 to $178.95, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":93780,"source":{"system":"sec-edgar","filing":"0001415889-24-008760","document":"form4-03202024_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924008760/form4-03202024_050301.xml","form_type":"4"}},{"id":42701,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-20T21:00:11.000Z","date":"2024-03-18","kind":"exercise","planned":false,"acquired":true,"shares":26110,"price":61.36,"value":1602109.6,"ownership":{"direct":true},"balance_after":119890,"source":{"system":"sec-edgar","filing":"0001415889-24-008760","document":"form4-03202024_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924008760/form4-03202024_050301.xml","form_type":"4"}},{"id":44464,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-03-01T22:50:34.000Z","date":"2024-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":26121,"price":178.99,"value":4675397.79,"ownership":{"direct":true},"balance_after":93780,"source":{"system":"sec-edgar","filing":"0001415889-24-006161","document":"form4-03012024_050315.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924006161/form4-03012024_050315.xml","form_type":"4"}},{"id":45447,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Option (Right to Buy)","published_at":"2024-02-20T22:15:24.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":39085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 13,029 on February 15, 2025, 13,028 on February 15, 2026, and 13,028 on February 15, 2027."}],"balance_after":39085,"derivative":{"exercise_price":0,"exercise_date":"2025-02-15","expiration_date":"2034-02-14","underlying":"Common Stock","underlying_shares":39085},"source":{"system":"sec-edgar","filing":"0001415889-24-004417","document":"form4-02202024_050210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004417/form4-02202024_050210.xml","form_type":"4"}},{"id":45446,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:24.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":9268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 16, 2023. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":119901,"source":{"system":"sec-edgar","filing":"0001415889-24-004417","document":"form4-02202024_050210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004417/form4-02202024_050210.xml","form_type":"4"}},{"id":45445,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:24.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":7840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":110633,"source":{"system":"sec-edgar","filing":"0001415889-24-004417","document":"form4-02202024_050210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004417/form4-02202024_050210.xml","form_type":"4"}},{"id":45444,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:24.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":8810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on invested capital measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":102793,"source":{"system":"sec-edgar","filing":"0001415889-24-004417","document":"form4-02202024_050210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004417/form4-02202024_050210.xml","form_type":"4"}},{"id":45443,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2024-02-20T22:15:24.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":33042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2024."}],"balance_after":93983,"source":{"system":"sec-edgar","filing":"0001415889-24-004417","document":"form4-02202024_050210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588924004417/form4-02202024_050210.xml","form_type":"4"}},{"id":57389,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Option (Right to Buy)","published_at":"2023-03-15T21:00:13.000Z","date":"2023-03-13","kind":"exercise","acquired":false,"shares":21810,"price":54.86,"value":1196496.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":54.86,"exercise_date":"2017-02-18","expiration_date":"2026-02-17","underlying":"Common Stock","underlying_shares":21810},"source":{"system":"sec-edgar","filing":"0001415889-23-004956","document":"form4-03152023_050301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923004956/form4-03152023_050301.xml","form_type":"4"}},{"id":57388,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-03-15T21:00:13.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":31315,"price":152.27,"value":4768335.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.79 to $152.73 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60941,"source":{"system":"sec-edgar","filing":"0001415889-23-004956","document":"form4-03152023_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923004956/form4-03152023_050301.xml","form_type":"4"}},{"id":57387,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-03-15T21:00:13.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":21810,"price":152.3,"value":3321663.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.79 to $152.73 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":92256,"source":{"system":"sec-edgar","filing":"0001415889-23-004956","document":"form4-03152023_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923004956/form4-03152023_050301.xml","form_type":"4"}},{"id":57386,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF COMMERCIAL OFFICER"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-03-15T21:00:13.000Z","date":"2023-03-13","kind":"exercise","acquired":true,"shares":21810,"price":54.86,"value":1196496.6,"ownership":{"direct":true},"balance_after":114066,"source":{"system":"sec-edgar","filing":"0001415889-23-004956","document":"form4-03152023_050301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923004956/form4-03152023_050301.xml","form_type":"4"}},{"id":57875,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COMMERCIAL OPERATIONS"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-03-02T22:02:41.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":24910,"price":154.28,"value":3843114.8,"ownership":{"direct":true},"balance_after":92256,"source":{"system":"sec-edgar","filing":"0001415889-23-003852","document":"form4-03022023_100330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923003852/form4-03022023_100330.xml","form_type":"4"}},{"id":58492,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COMMERCIAL OPERATIONS"}}],"security":"Option (Right to Buy)","published_at":"2023-02-21T23:02:09.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":35111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,704 on February 16, 2024, 11,704 on February 16, 2025, and 11,703 on February 16, 2026."}],"balance_after":35111,"derivative":{"exercise_price":149.62,"exercise_date":"2024-02-16","expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":35111},"source":{"system":"sec-edgar","filing":"0001415889-23-002937","document":"form4-02212023_110234.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002937/form4-02212023_110234.xml","form_type":"4"}},{"id":58491,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COMMERCIAL OPERATIONS"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:02:09.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":7842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 17, 2022. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":117166,"source":{"system":"sec-edgar","filing":"0001415889-23-002937","document":"form4-02212023_110234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002937/form4-02212023_110234.xml","form_type":"4"}},{"id":58490,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COMMERCIAL OPERATIONS"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:02:09.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":8812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":109324,"source":{"system":"sec-edgar","filing":"0001415889-23-002937","document":"form4-02212023_110234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002937/form4-02212023_110234.xml","form_type":"4"}},{"id":58489,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COMMERCIAL OPERATIONS"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:02:09.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":7486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance-vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":100512,"source":{"system":"sec-edgar","filing":"0001415889-23-002937","document":"form4-02212023_110234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002937/form4-02212023_110234.xml","form_type":"4"}},{"id":58488,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, COMMERCIAL OPERATIONS"}}],"security":"Common Stock, $0.01 par value","published_at":"2023-02-21T23:02:09.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":32085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2023."}],"balance_after":93026,"source":{"system":"sec-edgar","filing":"0001415889-23-002937","document":"form4-02212023_110234.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000141588923002937/form4-02212023_110234.xml","form_type":"4"}},{"id":68176,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Option (Right to Buy)","published_at":"2022-03-25T21:09:20.000Z","date":"2022-03-24","kind":"exercise","acquired":false,"shares":27690,"price":58.88,"value":1630387.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":58.88,"exercise_date":"2016-02-19","expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":27690},"source":{"system":"sec-edgar","filing":"0001179110-22-002416","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002416/edgar.xml","form_type":"4"}},{"id":68175,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-25T21:09:20.000Z","date":"2022-03-24","kind":"sale","acquired":false,"shares":27690,"price":159.2046,"value":4408375.374,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.86 to $159.55 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60941,"source":{"system":"sec-edgar","filing":"0001179110-22-002416","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002416/edgar.xml","form_type":"4"}},{"id":68174,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-25T21:09:20.000Z","date":"2022-03-24","kind":"exercise","acquired":true,"shares":27690,"price":58.88,"value":1630387.2,"ownership":{"direct":true},"balance_after":88631,"source":{"system":"sec-edgar","filing":"0001179110-22-002416","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022002416/edgar.xml","form_type":"4"}},{"id":69866,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:08:44.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":2600,"price":149.0357,"value":387492.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.86 to $149.48 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":60941,"source":{"system":"sec-edgar","filing":"0001179110-22-001832","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001832/edgar.xml","form_type":"4"}},{"id":69865,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:08:44.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":12659,"price":148.4935,"value":1879779.2165,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.86 to $148.85 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":63541,"source":{"system":"sec-edgar","filing":"0001179110-22-001832","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001832/edgar.xml","form_type":"4"}},{"id":69864,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:08:44.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":6229,"price":147.4276,"value":918326.5204,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.86 to $147.85 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":76200,"source":{"system":"sec-edgar","filing":"0001179110-22-001832","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001832/edgar.xml","form_type":"4"}},{"id":69863,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-03-01T23:08:44.000Z","date":"2022-02-25","kind":"tax_withholding","acquired":false,"shares":17093,"price":149.54,"value":2556087.22,"ownership":{"direct":true},"balance_after":82429,"source":{"system":"sec-edgar","filing":"0001179110-22-001832","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001832/edgar.xml","form_type":"4"}},{"id":70217,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Option (Right to Buy)","published_at":"2022-02-22T22:42:12.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":37215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 12,405 on February 17, 2023, 12,405 on February 17, 2024, and 12,405 on February 17, 2025."}],"balance_after":37215,"derivative":{"exercise_price":144.54,"exercise_date":"2023-02-17","expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":37215},"source":{"system":"sec-edgar","filing":"0001179110-22-001519","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001519/edgar.xml","form_type":"4"}},{"id":70216,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:42:12.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":13837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of AbbVie common stock issued under a cliff vesting restricted stock unit award granted to the reporting person on February 17, 2022. The shares will vest in their entirety on the third anniversary of the grant date, subject to the reporting person's continued employment at AbbVie on such date."}],"balance_after":99522,"source":{"system":"sec-edgar","filing":"0001179110-22-001519","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001519/edgar.xml","form_type":"4"}},{"id":70215,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:42:12.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":7710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2021. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":85685,"source":{"system":"sec-edgar","filing":"0001179110-22-001519","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001519/edgar.xml","form_type":"4"}},{"id":70214,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:42:12.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":7486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":77975,"source":{"system":"sec-edgar","filing":"0001179110-22-001519","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001519/edgar.xml","form_type":"4"}},{"id":70213,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:42:12.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":4176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":70489,"source":{"system":"sec-edgar","filing":"0001179110-22-001519","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001519/edgar.xml","form_type":"4"}},{"id":70212,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2022-02-22T22:42:12.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":19209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2022."}],"balance_after":66313,"source":{"system":"sec-edgar","filing":"0001179110-22-001519","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911022001519/edgar.xml","form_type":"4"}},{"id":74118,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-12-17T22:01:25.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":2152,"price":128,"value":275456.0,"ownership":{"direct":true},"balance_after":47104,"source":{"system":"sec-edgar","filing":"0001179110-21-011109","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021011109/edgar.xml","form_type":"4"}},{"id":74348,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-12-14T22:00:01.000Z","date":"2021-12-10","kind":"tax_withholding","acquired":false,"shares":1713,"price":124.15,"value":212668.95,"ownership":{"direct":true},"balance_after":49256,"source":{"system":"sec-edgar","filing":"0001179110-21-010956","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021010956/edgar.xml","form_type":"4"}},{"id":92098,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-03-03T01:26:57.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":13773,"price":108.5875,"value":1495575.6375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.34 to $108.88 inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50969,"source":{"system":"sec-edgar","filing":"0001179110-21-002594","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002594/edgar.xml","form_type":"4"}},{"id":92097,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-03-03T01:26:57.000Z","date":"2021-02-28","kind":"tax_withholding","acquired":false,"shares":10957,"price":107.74,"value":1180507.18,"ownership":{"direct":true},"balance_after":64742,"source":{"system":"sec-edgar","filing":"0001179110-21-002594","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002594/edgar.xml","form_type":"4"}},{"id":92746,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Option (right to buy)","published_at":"2021-02-22T23:19:35.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":43478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,493 on February 18, 2022 14,493 on February 18, 2023, and 14,492 on February 18, 2024."}],"balance_after":43478,"derivative":{"exercise_price":105.92,"exercise_date":"2022-02-18","expiration_date":"2031-02-17","underlying":"Common","underlying_shares":43478},"source":{"system":"sec-edgar","filing":"0001179110-21-002048","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002048/edgar.xml","form_type":"4"}},{"id":92745,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:19:35.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":7486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 20, 2020. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":75699,"source":{"system":"sec-edgar","filing":"0001179110-21-002048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002048/edgar.xml","form_type":"4"}},{"id":92744,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:19:35.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":4176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":68213,"source":{"system":"sec-edgar","filing":"0001179110-21-002048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002048/edgar.xml","form_type":"4"}},{"id":92743,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:19:35.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":2970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":64037,"source":{"system":"sec-edgar","filing":"0001179110-21-002048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002048/edgar.xml","form_type":"4"}},{"id":92742,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2021-02-22T23:19:35.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":10098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2021."}],"balance_after":61067,"source":{"system":"sec-edgar","filing":"0001179110-21-002048","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911021002048/edgar.xml","form_type":"4"}},{"id":96067,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial Operations"}}],"security":"Option (Right to buy)","published_at":"2020-12-31T18:15:33.000Z","date":"2020-12-29","kind":"exercise","acquired":true,"shares":25290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3."}],"balance_after":0,"derivative":{"exercise_price":51.42,"exercise_date":"2015-02-20","expiration_date":"2024-02-19","underlying":"Common stock","underlying_shares":25290},"source":{"system":"sec-edgar","filing":"0001179110-20-012333","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020012333/edgar.xml","form_type":"4"}},{"id":96066,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-12-31T18:15:33.000Z","date":"2020-12-29","kind":"sale","acquired":false,"shares":25290,"price":105,"value":2655450.0,"ownership":{"direct":true},"balance_after":50969,"source":{"system":"sec-edgar","filing":"0001179110-20-012333","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020012333/edgar.xml","form_type":"4"}},{"id":96065,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-12-31T18:15:33.000Z","date":"2020-12-29","kind":"exercise","acquired":true,"shares":25290,"price":51.42,"value":1300411.8,"ownership":{"direct":true},"balance_after":76259,"source":{"system":"sec-edgar","filing":"0001179110-20-012333","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020012333/edgar.xml","form_type":"4"}},{"id":96984,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-12-11T21:31:24.000Z","date":"2020-12-10","kind":"tax_withholding","acquired":false,"shares":1791,"price":108.67,"value":194627.97,"ownership":{"direct":true},"balance_after":50969,"source":{"system":"sec-edgar","filing":"0001179110-20-011832","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020011832/edgar.xml","form_type":"4"}},{"id":104903,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-05-12T21:44:46.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":23024,"price":90.0022,"value":2072210.6528,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.01, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":52760,"source":{"system":"sec-edgar","filing":"0001179110-20-005830","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020005830/edgar.xml","form_type":"4"}},{"id":106567,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-03-03T21:57:36.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":9703,"price":85.42,"value":828830.26,"ownership":{"direct":true},"balance_after":75784,"source":{"system":"sec-edgar","filing":"0001179110-20-002868","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002868/edgar.xml","form_type":"4"}},{"id":107180,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Option (right to buy)","published_at":"2020-02-24T22:59:42.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":49099,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,367 on February 20, 2021, 16,366 on February 20, 2022, and 16,366 on February 20, 2023."}],"balance_after":49099,"derivative":{"exercise_price":93.5,"exercise_date":"2021-02-20","expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":49099},"source":{"system":"sec-edgar","filing":"0001179110-20-002128","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002128/edgar.xml","form_type":"4"}},{"id":107179,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T22:59:42.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":4176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 21, 2019. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":85487,"source":{"system":"sec-edgar","filing":"0001179110-20-002128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002128/edgar.xml","form_type":"4"}},{"id":107178,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T22:59:42.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":2970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":81311,"source":{"system":"sec-edgar","filing":"0001179110-20-002128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002128/edgar.xml","form_type":"4"}},{"id":107177,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T22:59:42.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":3910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":78341,"source":{"system":"sec-edgar","filing":"0001179110-20-002128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002128/edgar.xml","form_type":"4"}},{"id":107176,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2020-02-24T22:59:42.000Z","date":"2020-02-20","kind":"grant","acquired":true,"shares":10840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on earnings per share and relative total shareholder return. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2020."}],"balance_after":74431,"source":{"system":"sec-edgar","filing":"0001179110-20-002128","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911020002128/edgar.xml","form_type":"4"}},{"id":109865,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common Stock, $0.01 par value","published_at":"2019-12-12T21:22:45.000Z","date":"2019-12-10","kind":"tax_withholding","acquired":false,"shares":1713,"price":86.44,"value":148071.72,"ownership":{"direct":true},"balance_after":63591,"source":{"system":"sec-edgar","filing":"0001179110-19-012716","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019012716/edgar.xml","form_type":"4"}},{"id":113884,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common stock, $0.01 par value","published_at":"2019-08-20T20:16:25.000Z","date":"2019-08-16","kind":"purchase","acquired":true,"shares":15552,"price":64.4399,"value":1002169.3248,"ownership":{"direct":true},"balance_after":65304,"source":{"system":"sec-edgar","filing":"0001179110-19-009703","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019009703/edgar.xml","form_type":"4"}},{"id":118964,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common stock, $0.01 par value","published_at":"2019-03-04T22:00:11.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":6907,"price":79.41,"value":548484.87,"ownership":{"direct":true},"balance_after":49752,"source":{"system":"sec-edgar","filing":"0001179110-19-003097","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019003097/edgar.xml","form_type":"4"}},{"id":119505,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Option (Right to buy)","published_at":"2019-02-22T22:17:51.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":25700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 8,567 on February 21, 2020, 8,566 on February 21, 2021, and 8,567 on February 21, 2022."}],"balance_after":25700,"derivative":{"exercise_price":79.02,"exercise_date":"2020-02-21","expiration_date":"2029-02-20","underlying":"Common Stock","underlying_shares":25700},"source":{"system":"sec-edgar","filing":"0001179110-19-002363","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002363/edgar.xml","form_type":"4"}},{"id":119504,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:17:51.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":2970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 15, 2018. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":56659,"source":{"system":"sec-edgar","filing":"0001179110-19-002363","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002363/edgar.xml","form_type":"4"}},{"id":119503,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:17:51.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":3909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 16, 2017. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":53689,"source":{"system":"sec-edgar","filing":"0001179110-19-002363","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002363/edgar.xml","form_type":"4"}},{"id":119502,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:17:51.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":3645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of AbbVie common stock issued under a performance vesting restricted stock unit award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":49780,"source":{"system":"sec-edgar","filing":"0001179110-19-002363","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002363/edgar.xml","form_type":"4"}},{"id":119501,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common stock, $0.01 par value","published_at":"2019-02-22T22:17:51.000Z","date":"2019-02-21","kind":"grant","acquired":true,"shares":5062,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of AbbVie common stock issued under a performance share award granted to the reporting person on February 18, 2016. The award is subject to performance-vesting restrictions based on a relative return on equity measure. The performance-vesting restrictions with respect to these shares were released on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of AbbVie's Board of Directors. The shares will be issued to the reporting person on February 28, 2019."}],"balance_after":46135,"source":{"system":"sec-edgar","filing":"0001179110-19-002363","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911019002363/edgar.xml","form_type":"4"}},{"id":121885,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common stock, $0.01 par value","published_at":"2018-12-13T01:38:46.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":11595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent restricted stock units granted under the AbbVie 2013 Incentive Stock Program. They vest in annual increments of 3,865 shares on each of 12/10/2019, 12/10/2020 and 12/10/2021, and include the right to have stock withheld for tax purposes."}],"balance_after":41073,"source":{"system":"sec-edgar","filing":"0001179110-18-013808","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018013808/edgar.xml","form_type":"4/A","original_submission_date":"2018-12-12"}},{"id":121886,"issuer":{"id":2800,"kind":"organization","name":"AbbVie Inc."},"owners":[{"id":11034,"kind":"person","name":"Stewart Jeffrey Ryan","position":1,"cik":"0001761675","reported_name":"Stewart Jeffrey Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, US Commercial Operations"}}],"security":"Common stock, $0.01 par value","published_at":"2018-12-12T23:17:07.000Z","date":"2018-12-10","kind":"grant","acquired":true,"shares":11595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent restricted stock units granted under the AbbVie 2013 Incentive Stock Program. They vest in annual increments of 21,514 on 12/09/2016, 21,513 on 12/09/2017, and 21,513 on 12/09/2018, and include the right to have stock withheld for tax purposes."}],"balance_after":41073,"source":{"system":"sec-edgar","filing":"0001179110-18-013777","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551152/000117911018013777/edgar.xml","form_type":"4"}}]}